Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: risdiplam | Statement: [JEWELFISH, hasOralFormulation, risdiplam]

Target entity: risdiplam
Context triple: [JEWELFISH, hasOralFormulation, risdiplam]

• A. risdiplam chosen
  Risdiplam is an oral small-molecule drug used to treat spinal muscular atrophy by increasing production of functional survival motor neuron (SMN) protein.
• B. Matignon Accords
  The Matignon Accords are a series of 1988 agreements that sought to end violent conflict and redefine political and economic relations in New Caledonia, particularly addressing the self-determination aspirations of the indigenous Kanak people.
• C. Gruber–De Gasperi Agreement
  The Gruber–De Gasperi Agreement was a 1946 accord between Italy and Austria that laid the foundation for the autonomous status and minority protections of the German-speaking population in the South Tyrol region.
• D. Sikorski–Mayski agreement
  The Sikorski–Mayski agreement was a 1941 pact between the Polish government-in-exile and the Soviet Union that restored diplomatic relations and led to an "amnesty" for many Polish citizens imprisoned or deported in the USSR during World War II.
• E. Gianti Agreement
  The Gianti Agreement was an 18th-century treaty that divided the Javanese Mataram Sultanate, reshaping political power in central Java under Dutch colonial influence.
• F. None of above.
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Target predicate: hasOralFormulation
Context triple: [JEWELFISH, hasOralFormulation, risdiplam]

• A. hasDosageForm
  Indicates the specific physical form or presentation in which a drug or medicinal product is supplied or administered (e.g., tablet, injection, cream).
• B. isOralFormOf chosen
  Indicates that one entity is the oral (by-mouth) dosage form or version of another entity, typically a drug or medicinal product.
• C. isExtendedReleaseFormulationOf
  Indicates that one pharmaceutical formulation is an extended-release version of another, designed to release the active ingredient more slowly over time.
• D. hasRouteOfAdministration
  Indicates that one entity specifies the method or pathway by which another entity (typically a substance or medication) is administered.
• E. formulatedIn
  Indicates that something was created, developed, or expressed within a particular context, place, or framework.
• F. None of above.